Vontobel Holding Ltd. Invests $370,000 in Oscar Health, Inc. (NYSE:OSCR)

Vontobel Holding Ltd. purchased a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 27,526 shares of the company's stock, valued at approximately $370,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp boosted its stake in Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock valued at $108,867,000 after buying an additional 291,335 shares during the period. GDS Wealth Management lifted its holdings in shares of Oscar Health by 1,545.3% during the fourth quarter. GDS Wealth Management now owns 345,817 shares of the company's stock valued at $4,648,000 after purchasing an additional 324,798 shares in the last quarter. Nordea Investment Management AB bought a new stake in Oscar Health during the fourth quarter valued at approximately $1,056,000. Versor Investments LP purchased a new stake in Oscar Health in the 3rd quarter worth $787,000. Finally, Janney Montgomery Scott LLC bought a new position in shares of Oscar Health during the 3rd quarter valued at approximately $988,000. Institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on OSCR. Jefferies Financial Group started coverage on Oscar Health in a report on Tuesday, December 10th. They set an "underperform" rating and a $12.00 target price for the company. Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and reduced their target price for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $21.56.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 6,516 shares of Oscar Health stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $117,809.28. Following the completion of the transaction, the insider now directly owns 81,962 shares of the company's stock, valued at $1,481,872.96. The trade was a 7.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Ranmali Bopitiya sold 19,157 shares of Oscar Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $346,358.56. Following the completion of the sale, the executive vice president now owns 241,488 shares of the company's stock, valued at $4,366,103.04. This trade represents a 7.35 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 78,610 shares of company stock valued at $1,421,269. Company insiders own 25.11% of the company's stock.

Oscar Health Stock Performance

Shares of Oscar Health stock traded down $1.26 during trading on Friday, reaching $14.81. The company's stock had a trading volume of 6,082,590 shares, compared to its average volume of 4,542,156. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. Oscar Health, Inc. has a one year low of $12.43 and a one year high of $23.79. The business's fifty day moving average price is $14.79 and its 200-day moving average price is $16.69. The firm has a market cap of $3.66 billion, a price-to-earnings ratio of -740.33 and a beta of 1.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.